Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Francis W. Price Jr., MD, of Price Vision Group, discusses the latest in neurotrophic keratitis.
Price said pharmaceuticals are under study for neurotrophic keratitis, nonhealing epithelial defects and limbal stem cell deficiency. There are also new forms of amniotic membrane.
“We’re on the verge of some pretty exciting breakthroughs for these problems that have plagued some of our patients for a long time,” Price told Healio. “There are a lot of things in the pipeline. Keep your eyes open for